This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Shanghai Superb Medical Technology Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Feng Ding in Medical Technology
Introduction
Feng Ding is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medical technology, particularly in dialysis solutions. With a total of 2 patents, his work focuses on improving patient care through innovative medical solutions.
Latest Patents
Feng Ding's latest patents include a fat emulsion dialysate and a regional citrate anticoagulation infusion system. The fat emulsion dialysate is designed for hemodialysis and peritoneal dialysis, offering advantages in protein-bound toxin removal compared to traditional dialysis methods. This invention features a composition that includes long-chain fat emulsion oil, medium-chain triglyceride, and other essential components, ensuring stability and safety for up to 14 days at room temperature. The regional citrate anticoagulation infusion system provides a method for controlling the infusion rotation speed of citrate and calcium pumps, enhancing the efficiency of anticoagulation during dialysis procedures.
Career Highlights
Feng Ding is associated with Shanghai Superb Medical Technology Co., Ltd., where he continues to develop innovative medical technologies. His work has the potential to transform dialysis practices and improve patient outcomes significantly.
Collaborations
Feng Ding collaborates with notable colleagues, including Chaobin Wang and Damin Ding, to advance research and development in medical technology.
Conclusion
Feng Ding's contributions to medical technology through his patents reflect his commitment to enhancing healthcare solutions. His innovative approaches in dialysis technology hold promise for better patient care and improved treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile